Cancer discovery | 2019

Tumor Burden Affects Efficacy of Combination Immunotherapy.

 

Abstract

Combined CTLA4 and PD-L1 blockade hinders antitumor immunity in patients with low tumor burden.

Volume 9 4
Pages \n OF11\n
DOI 10.1158/2159-8290.CD-RW2019-021
Language English
Journal Cancer discovery

Full Text